March 2013 Vol 3 I No 1
Journal OF
hematology Oncology ™ Pharmacy The Peer-Reviewed Forum for Oncology Pharmacy Practice
TM
ORIGINAL RESEARCH
Pharmacist Assessment of Polypharmacy Risks in Patients with Cancer Robert Mancini, PharmD, BCOP; Kathleen Clifford, MSN, FNP-BC, AOCNP, ACHPN Review article
Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma Michael K. Wong, MD, PhD, FRCPC; Anthony Jarkowski III, PharmD, BCOP
From the Literature Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy By Robert J. Ignoffo, PharmD, FASHP, FCSHP, Section Editor
WWW.JHOPONLINE.COM
©2013 Green Hill Healthcare Communications, LLC